IL149045A0 - Diagnosis and therapy of cancer using sgp28-related molecules - Google Patents
Diagnosis and therapy of cancer using sgp28-related moleculesInfo
- Publication number
- IL149045A0 IL149045A0 IL14904500A IL14904500A IL149045A0 IL 149045 A0 IL149045 A0 IL 149045A0 IL 14904500 A IL14904500 A IL 14904500A IL 14904500 A IL14904500 A IL 14904500A IL 149045 A0 IL149045 A0 IL 149045A0
- Authority
- IL
- Israel
- Prior art keywords
- sgp28
- diagnosis
- therapy
- cancer
- related molecules
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 101000726258 Homo sapiens Cysteine-rich secretory protein 3 Proteins 0.000 abstract 3
- 102100027367 Cysteine-rich secretory protein 3 Human genes 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4721—Cationic antimicrobial peptides, e.g. defensins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Pregnancy & Childbirth (AREA)
- Transplantation (AREA)
- Gynecology & Obstetrics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16261099P | 1999-10-28 | 1999-10-28 | |
| PCT/US2000/029607 WO2001031343A2 (en) | 1999-10-28 | 2000-10-27 | Diagnosis and therapy of cancer using sgp28-related molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL149045A0 true IL149045A0 (en) | 2002-11-10 |
Family
ID=22586387
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14904500A IL149045A0 (en) | 1999-10-28 | 2000-10-27 | Diagnosis and therapy of cancer using sgp28-related molecules |
| IL149045A IL149045A (en) | 1999-10-28 | 2002-04-09 | Diagnosis and therapy of cancer using sgp28-related molecules |
| IL207012A IL207012A (he) | 1999-10-28 | 2010-07-15 | תכשיר רפואי המכיל 28sgp ותכשיר חיסוני לטיפול בסרטן המבטא 28sgp |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL149045A IL149045A (en) | 1999-10-28 | 2002-04-09 | Diagnosis and therapy of cancer using sgp28-related molecules |
| IL207012A IL207012A (he) | 1999-10-28 | 2010-07-15 | תכשיר רפואי המכיל 28sgp ותכשיר חיסוני לטיפול בסרטן המבטא 28sgp |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1228373B1 (he) |
| JP (2) | JP3779926B2 (he) |
| AT (1) | ATE291738T1 (he) |
| AU (1) | AU781223B2 (he) |
| CA (1) | CA2386865C (he) |
| DE (1) | DE60018964T2 (he) |
| ES (1) | ES2240192T3 (he) |
| IL (3) | IL149045A0 (he) |
| WO (1) | WO2001031343A2 (he) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6835822B1 (en) | 1999-10-28 | 2004-12-28 | Agensys, Inc. | Diagnosis and therapy of cancer using SGP28-related molecules |
| US7405202B2 (en) | 2002-05-28 | 2008-07-29 | Regents Of The University Of Minnesota | CRISP polypeptides as contraceptives and inhibitors of sperm capacitation |
| CA2680556A1 (en) * | 2007-03-12 | 2008-09-18 | Miraculins Inc. | Biomarkers of prostate cancer and uses thereof |
| AU2010328078B2 (en) | 2009-12-11 | 2013-07-04 | Covidien Lp | Material removal device having improved material capture efficiency and methods of use |
| CN102914658A (zh) * | 2012-10-24 | 2013-02-06 | 高维强 | Crisp3蛋白在前列腺癌诊断和治疗中的应用 |
-
2000
- 2000-10-27 AU AU12372/01A patent/AU781223B2/en not_active Ceased
- 2000-10-27 JP JP2001533429A patent/JP3779926B2/ja not_active Expired - Fee Related
- 2000-10-27 AT AT00973927T patent/ATE291738T1/de not_active IP Right Cessation
- 2000-10-27 DE DE60018964T patent/DE60018964T2/de not_active Expired - Lifetime
- 2000-10-27 IL IL14904500A patent/IL149045A0/xx unknown
- 2000-10-27 CA CA2386865A patent/CA2386865C/en not_active Expired - Fee Related
- 2000-10-27 WO PCT/US2000/029607 patent/WO2001031343A2/en active Application Filing
- 2000-10-27 ES ES00973927T patent/ES2240192T3/es not_active Expired - Lifetime
- 2000-10-27 EP EP00973927A patent/EP1228373B1/en not_active Expired - Lifetime
-
2002
- 2002-04-09 IL IL149045A patent/IL149045A/en not_active IP Right Cessation
-
2006
- 2006-01-27 JP JP2006019870A patent/JP4325943B2/ja not_active Expired - Fee Related
-
2010
- 2010-07-15 IL IL207012A patent/IL207012A/he not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU781223B2 (en) | 2005-05-12 |
| DE60018964D1 (de) | 2005-04-28 |
| IL149045A (en) | 2010-11-30 |
| ATE291738T1 (de) | 2005-04-15 |
| AU1237201A (en) | 2001-05-08 |
| DE60018964T2 (de) | 2006-01-12 |
| WO2001031343A3 (en) | 2002-01-31 |
| IL207012A (he) | 2013-05-30 |
| WO2001031343A2 (en) | 2001-05-03 |
| CA2386865A1 (en) | 2001-05-03 |
| EP1228373B1 (en) | 2005-03-23 |
| JP4325943B2 (ja) | 2009-09-02 |
| JP2003512825A (ja) | 2003-04-08 |
| CA2386865C (en) | 2012-05-22 |
| IL207012A0 (en) | 2011-08-01 |
| JP3779926B2 (ja) | 2006-05-31 |
| JP2006187290A (ja) | 2006-07-20 |
| EP1228373A2 (en) | 2002-08-07 |
| ES2240192T3 (es) | 2005-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE330967T1 (de) | An her2 bindende peptidverbindungen | |
| WO2004050707A3 (de) | Tumorspezifische erkennungsmoleküle | |
| MXPA03000527A (es) | Composiciones y metodos para la terapia y diagnostico de cancer ovarico. | |
| WO2003004989A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| WO2006089230A3 (en) | Human monoclonal antibodies to prostate specific membrane antigen (psma) | |
| WO2001008636A8 (en) | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein | |
| WO2002071928A3 (en) | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | |
| WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
| TW200635946A (en) | Binding proteins specific for human matriptase | |
| WO2004106495A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
| WO2006028429A3 (en) | Peptides for targeting the prostate specific membrane antigen | |
| WO2001055178A3 (en) | Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer | |
| IL207012A0 (en) | Diagnosis and therapy of cancer using sgp28-related molecules | |
| WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
| WO2004076614A3 (de) | Humane nukleinsäuresequenzen aus prostatakarzinomen | |
| WO2003044161A3 (en) | Gene amplification and overexpression in cancer | |
| WO2004066933A3 (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
| WO2003048317A3 (en) | Antibodies to magmas and uses thereof | |
| WO2004078130A3 (en) | Posh interacting proteins and related methods | |
| WO2004020591A3 (en) | Methods of use for novel human polypeptides encoded by polynucleotides | |
| WO2004078918A3 (en) | Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides | |
| WO2002064838A3 (en) | Amplified cancer gene wip1 | |
| WO2001055391A3 (en) | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer | |
| WO2000020638A3 (en) | Methods and compositions for the diagnosis and therapy of prostate cancer |